We discuss how the recent revelation that gadolinium (Gd) from commercially available MRI contrast agents is irreversibly and cumulatively deposited in the central nervous system is driving innovation toward Gd-free contrast agents for neuroradiology.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994911 | PMC |
http://dx.doi.org/10.1021/acschemneuro.8b00044 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!